19 completed. 19 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 19 | Completed 19 |
| Phase 1 | 1 | Completed 1 |
Follow Biospecimen Collection: new trials by email Literature Review of Biospecimen Collection trials Research Report on Biospecimen Collection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Canakinumab in High-Risk Former-Smokers Biospecimen Collection, Bronchoscopy, Canakinumab - Cigarette Smoking-Related Carcinoma, Lung Carcinoma | Phase 2 | Completed | Peter Shields | 41 | 2024-03-11 | 2026-07-07 |
| Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer Biopsy, Biospecimen Collection, Computed Tomography - Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | Completed | Mayo Clinic | 7 | 2024-03-08 | 2026-06-09 |
| Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma Biospecimen Collection, Cyclophosphamide, Echocardiography - Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma | Phase 2 | Completed | University of Kansas Medical Center | 11 | 2023-12-21 | 2026-04-30 |
| A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 - Chronic Lymphocytic Leukemia, COVID-19 Infection | Phase 2 | Completed | City of Hope Medical Center | 47 | 2023-08-01 | 2026-09-09 |
| Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) Treosulfan, Fludarabine Phosphate, Tacrolimus - Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia | Phase 2 | Completed | Fred Hutchinson Cancer Center | 40 | 2022-04-19 | 2026-03-09 |
| Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma Mosunetuzumab, Obinutuzumab, Polatuzumab Vedotin - Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma | Phase 2 | Completed | University of Washington | 42 | 2022-03-23 | 2026-05-13 |
| Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy Anakinra, X-Ray Imaging, Positron Emission Tomography - B-Cell Non-Hodgkin Lymphoma | Phase 2 | Completed | Fred Hutchinson Cancer Center | 27 | 2021-12-27 | 2025-10-23 |
| Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland Apalutamide, Biospecimen Collection, Quality-of-Life Assessment - Localized Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2021-07-23 | 2026-06-25 |
| Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Carboplatin, Pembrolizumab, Computed Tomography - Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma | Phase 2 | Completed | University of Washington | 22 | 2021-03-18 | 2026-06-29 |
| Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma Atezolizumab, Biopsy, Biospecimen Collection - Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 47 | 2019-06-05 | 2024-07-26 |
| Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study Pembrolizumab, Quality-of-Life Assessment, Computed Tomography - Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 | Phase 2 | Completed | M.D. Anderson Cancer Center | 45 | 2018-11-13 | 2026-04-16 |
| Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer Atezolizumab, Biopsy, Biospecimen Collection - Gallbladder Carcinoma, Metastatic Cholangiocarcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 86 | 2018-02-08 | 2024-04-05 |
| Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) Biospecimen Collection, Computed Tomography, FDG-Positron Emission Tomography - Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma | Phase 2 | Completed | National Cancer Institute (NCI) | 18 | 2017-11-28 | 2026-04-21 |
| TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer Anastrozole, Denifanstat, Exemestane - Advanced Breast Carcinoma, HER2-Positive Breast Carcinoma | Phase 2 | Completed | Mayo Clinic | 17 | 2017-08-03 | 2026-10-09 |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Cirrhosis, Hepatocellular Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 52 | 2017-06-21 | 2026-09-09 |
| Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement Azacitidine, Biospecimen Collection, Computed Tomography - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Completed | National Cancer Institute (NCI) | 78 | 2017-04-01 | 2025-02-27 |
| Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed Biospecimen Collection, Bone Scan, Cabozantinib S-malate - Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 152 | 2016-07-25 | 2025-01-13 |
| Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer Biopsy, Biospecimen Collection, Computed Tomography - Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 27 | 2013-10-08 | 2025-01-14 |
| Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer Biopsy, Biospecimen Collection, Carboplatin - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 2 | Completed | National Cancer Institute (NCI) | 77 | 2010-06-30 | 2025-08-15 |
Lung Neoplasms (2) · Lymphoma, Non-Hodgkin (2) · Melanoma (2) · Prostatic Neoplasms (2) · Anemia, Diamond-Blackfan (1) · Anemia, Hypochromic (1) · Bone Marrow Failure Disorders (1) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · COVID-19 (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Central Nervous System Neoplasms (1)
National Cancer Institute (NCI) (9) · Fred Hutchinson Cancer Center (2) · Mayo Clinic (2) · University of Washington (2) · City of Hope Medical Center (1) · M.D. Anderson Cancer Center (1) · Peter Shields (1) · University of Kansas Medical Center (1)
United States (19) · Canada (3) · Puerto Rico (3) · Australia (1)
Alexey V Danilov (1) · Antoni Ribas (1) · Evan Y Yu (1) · Jacob Orme, M.D., Ph.D. (1) · Jianjun Zhang (1) · Joanne Mortimer (1) · John B. Liao (1) · Jordan Gauthier (1) · Juan Chipollini (1) · Lauri Burroughs, MD (1) · Marc T Goodman (1) · Margaret MacMillan, MD (1) · Muhammad Umair Mushtaq (1) · Nilofer S Azad (1) · Peter G Shields, MD (1)
PMID 31401903, PMID 33084020, PMID 33592176, PMID 34907910, PMID 37146227, PMID 38261444, PMID 38867582, PMID 39255440, PMID 40343719, PMID 42600120
P30CA015704 (2), P30CA033572 (2), U10CA180886 (2), U10CA180888 (2), N01CM00032 (1), N01CM00038 (1), N01CM00039 (1), N01CM00071 (1), N01CM00099 (1), N01CM62201 (1), N01CM62202 (1), N01CM62203 (1), N01CM62209 (1), N01CN00035 (1), P30CA023074 (1)